FDA agree to ‘Keytruda’ medicine as adjuvant treatment for kidney cancer
According to a news release from Merck, the cancer immunotherapy medicine Keytruda (pembrolizumab) was approved by the US Food and Drug Administration (FDA) on Thursday to aid in the fight…